603368 Guangxi LiuYao Group
- 18.13
- -0.13-0.71%
Guangxi LiuYao Group News
Guangxi Liuyao Group (603368): The three major business segments are gradually improving, accelerating expansion outside the province.
Event: In the third quarter of 2024, guangxi liuyao group achieved revenue of 5.351 billion yuan, a year-on-year increase of 1.49%; achieved net income attributable to the parent of 0.252 billion yuan, a year-on-year increase of 8.68%; in the first three quarters of 2024, achieved revenue
Guangxi Liuyao Group Co., Ltd. Report for the Third Quarter of 2024
Guangxi Liuyao Group (603368.SH) released its performance for the first three quarters, with a net income of 0.716 billion yuan, a year-on-year increase of 6.13%.
Guangxi Liuyao Group (603368.SH) disclosed the third quarter report of 2024, achieving a revenue of 15...
Guangxi Liuyao Group (603368.SH): The net income for the first three quarters was 0.716 billion yuan, a year-on-year increase of 6.13%.
格隆汇October 29th - Guangxi Liuyao Group (603368.SH) released its third quarter report, with revenue for the first three quarters reaching 15.99 billion yuan, a year-on-year increase of 2.41%, net income of 0.716 billion yuan, a year-on-year increase of 6.13%, non-net profit of 0.7 billion yuan, a year-on-year increase of 5.20%, and basic earnings per share of 1.87 yuan.
Guangxi Liuyao Group (603368.SH): 36.8421 million shares of restricted shares will be lifted on October 24th.
Guangxi Liuyao Group (603368.SH) announced that the total number of stocks listed this time is 36.8421 million shares. The stock listing date is October 24, 2024.
Guangxi Liuyao Group (603368.SH): As of August 31, 2024, the production capacity of traditional Chinese medicine formula granules has reached 1000 tons.
Guangxi Liuyao Group (603368.SH) announced that the company's traditional chinese medicine formulation granule project capacity: the total planned capacity of the project is 3,000 tons, with an initial capacity of 1,500 tons. From January to August 2024, the company actively promoted equipment introduction, process optimization, and equipment technological upgrading to accelerate capacity improvement. As of August 31, 2024, the capacity of the traditional chinese medicine formulation granule project reached 1,000 tons, effectively meeting the company's market expansion needs. At the same time, the company further accelerated capacity follow-up based on market development progress to ensure the company's supply advantages of traditional chinese medicine formulation granules. The company has a variety of traditional chinese medicine formulation granule varieties.
CP smart home AI health services will be launched this year. Guangxi Liuyao Group: The new online settlement policy is conducive to improving the current high accounts receivable situation. | Direct hit earnings conference
At the earnings conference, Chairman Zhu Chaoyang of Guangxi Liuyao Group introduced the progress of the company's AI scenario application business. For the high accounts receivable, the company's CFO Zeng Xiangxing stated that the company has adjusted its operational strategy and strengthened the collection efforts. Guangxi Liuyao Group also responded to the slight decline in growth of the pharmaceutical wholesale sector and issues related to the expansion of pharmaceutical new retail business.
Vice President Tang Xianrong of Guangxi Liuyao Group (603368.SH) reduced his shareholding by 0.02 million shares at the end of the shareholding period.
Guangxi Liuyao Group (603368.SH) announced that Vice President Tang Xianrong passed away on June 28, 2024 through centralized...
Guangxi Liuyao Group (603368): The growth rate of its distribution business has slowed down, waiting for improvements in the industry.
Event: In the first half of 2024, Guangxi Liuyao Group achieved a revenue of 10.642 billion yuan, a year-on-year growth of 2.88%; achieved a net income attributable to shareholders of 0.464 billion yuan, a year-on-year growth of 4.79%. The pharmaceutical wholesale business has been affected by policies and has made some adjustments.
Guangxi Liuyao Group Co., Ltd. 2024 Semi-Annual Report Report
Guangxi Liuyao Group Co., Ltd. 2024 Semi-Annual Report Report Summary
Guangxi Liuyao Group (603368.SH):
Guangxi Liuyao Group (603368.SH) announced its semi-annual report for 2024 on August 28th. During the reporting period, the company achieved revenue of 10.642 billion yuan, a year-on-year increase of 2.88%; net income attributable to shareholders of the listed company was 0.464 billion yuan, a year-on-year increase of 4.79%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.456 billion yuan, a year-on-year increase of 4.27%; basic earnings per share was 1.24 yuan.
Express News | Guangxi Liuyao Group: net income was 0.464 billion yuan in the first half of the year, a year-on-year increase of 4.79%.
Express News | guangxi liuyao group: net income in the first half of 2024 was 0.464 billion yuan, a year-on-year increase of 4.79%.
Express News | Guangxi Liuyao Group: net income in the first half of the year increased by 4.79% year-on-year.
Guangxi Liuyao Group (603368.SH): Granted 420,700 restricted stocks to 58 incentive targets.
Guangxi Liuyao Group (603368.SH) announced on June 14th that the company's board of directors believes that the restricted stock reserve grant conditions specified in the company's "Incentive Plan" have been achieved, and agreed to set the reservation grant date for the company's 2023 restricted stock incentive plan (referred to as "this incentive plan") as June 14, 2024, with a grant price of 10.22 yuan/share, granting 420,700 restricted stocks to 58 eligible incentive objects.
Guangxi Liuyao Group (603368.SH) annual equity distribution in 2023: 6 yuan per 10 shares, with record date on June 7.
Guangxi Liuyao Group (603368.SH) released the annual equity dividend implementation announcement for 2023. Based on the total equity capital registered on the stock registration date of the equity dividend (excluding shares repurchased and restricted stocks that are intended to be repurchased and cancelled) distributed 6 yuan (tax included) cash dividend to all shareholders for every 10 shares. The ex-dividend date is June 11, 2024, and the record date is June 7, 2024.
Liu Yao Bonds Transfer: Stock conversion will be suspended from June 3 due to 2023 equity distribution
Guangxi Liuyao Group Co., Ltd. announced that due to the implementation of equity distribution in 2023, “Liuyao Bonds Transfer” will stop transferring shares from June 3, 2024 until equity registration for equity distribution resumes at a later date. The share conversion price will be adjusted according to regulations.
Liu Pharmaceutical Group (603368.SH): The total number of pharmacies has reached 841, and plans to open 100 new stores throughout the year and increase the proportion of specialty pharmacies
Liu Yao Group (603368.SH) issued an announcement. On May 18, 2024, the company disclosed “About holding...
Is there no fixed increase in the public offering to invest? The year-on-year decline was nearly 70%. The fixed increase in subscriptions was less than 10 billion dollars. Zhu Shaoxing and Cao Mingchang each lost profits
① The total number of subscriptions to participate in the fixed increase from the public offering this year is only 30% of the same period last year; ② Western Lide and Huian Fund, which rarely “showed up” fixed growth projects, participated in fixed growth projects this year; ③ Cao Mingchang participated in Liuyao Group's fixed growth and fuying exceeded 15%, and Zhu Shaoxing's participation in Qianweiyang Chef's fixed growth and loss was over 15%.
Analysis
Price Target
No Data
No Data